The Hereditary Spherocytosis Market refers to the clinical landscape for diagnosing, treating, and managing hereditary spherocytosis (HS)—a rare, inherited hemolytic anemia characterized by abnormal red blood cell shape and increased fragility. HS is caused by genetic defects in red blood cell membrane proteins, leading to chronic hemolysis, anemia, jaundice, splenomegaly,...